Search
for
Sort by
Research 331–360 of 1000+
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Hoxc-Dependent Mesenchymal Niche Heterogeneity Drives Regional Hair Follicle Regeneration
- Fibroblast growth factor 5-short (FGF5s) inhibits the activity of FGF5 in primary and secondary hair follicle dermal papilla cells of cashmere goats
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- How to distinguish medicalization from over-medicalization?
- De Novo Production of Dermal Papilla Cells during the Anagen Phase of the Hair Cycle
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation
- Recent advances in oxasteroids chemistry
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- A Microarray-Based Analysis Reveals that a Short Photoperiod Promotes Hair Growth in the Arbas Cashmere Goat
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Update on the dermatologic use of systemic glucocorticosteroids
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Objective outcome measures: Collecting meaningful data on alopecia areata
- GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
- Effect of Adenovirus-Mediated Expression of Sonic Hedgehog Gene on Hair Regrowth in Mice With Chemotherapy-Induced Alopecia
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Aging in hair follicle stem cells and niche microenvironment
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Side effects of common acne treatments
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Redefining hormone resistance in prostate cancer
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Treatment of telogen effluvium using a dietary supplement containing <i>Boswellia serrata</i> , <i>Curcuma longa</i> , and <i>Vitis vinifera</i> : Results of an observational study